Oppenheimer Asset Management Inc. Takes Position in Astera Labs, Inc. $ALAB

Oppenheimer Asset Management Inc. bought a new stake in shares of Astera Labs, Inc. (NASDAQ:ALAB) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund bought 8,193 shares of the company’s stock, valued at approximately $3,957,000.

Other institutional investors and hedge funds have also bought and sold shares of the company. Atreides Management LP increased its stake in Astera Labs by 108.9% in the first quarter. Atreides Management LP now owns 3,365,787 shares of the company’s stock valued at $368,890,000 after purchasing an additional 1,754,593 shares in the last quarter. Amundi raised its holdings in shares of Astera Labs by 1,298.6% during the third quarter. Amundi now owns 1,421,263 shares of the company’s stock valued at $278,283,000 after purchasing an additional 1,319,643 shares during the period. Artisan Partners Limited Partnership bought a new position in shares of Astera Labs during the 4th quarter worth about $148,980,000. Goldman Sachs Group Inc. boosted its position in shares of Astera Labs by 189.0% during the 4th quarter. Goldman Sachs Group Inc. now owns 1,312,927 shares of the company’s stock worth $218,419,000 after purchasing an additional 858,693 shares in the last quarter. Finally, State Street Corp grew its stake in shares of Astera Labs by 32.5% in the 4th quarter. State Street Corp now owns 3,099,809 shares of the company’s stock valued at $515,684,000 after buying an additional 760,358 shares during the period. 60.47% of the stock is owned by institutional investors.

Astera Labs Price Performance

Shares of NASDAQ ALAB opened at $321.61 on Friday. The company has a 50-day moving average price of $358.00 and a 200-day moving average price of $240.20. The stock has a market capitalization of $55.80 billion, a P/E ratio of 159.21 and a beta of 3.84. Astera Labs, Inc. has a 1 year low of $97.89 and a 1 year high of $499.48.

Astera Labs (NASDAQ:ALAB) last posted its earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, topping analysts’ consensus estimates of $0.69 by $0.11. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The company had revenue of $392.40 million for the quarter, compared to analyst estimates of $360.85 million. During the same quarter in the prior year, the business posted $0.44 EPS. The firm’s revenue was up 104.5% compared to the same quarter last year. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. As a group, equities research analysts anticipate that Astera Labs, Inc. will post 2.7 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

ALAB has been the subject of a number of research analyst reports. Jefferies Financial Group boosted their target price on Astera Labs from $270.00 to $450.00 and gave the company a “buy” rating in a research report on Wednesday, August 5th. Morgan Stanley increased their price target on Astera Labs to $335.00 and gave the stock an “overweight” rating in a report on Monday, August 3rd. TD Cowen reduced their price objective on Astera Labs from $425.00 to $375.00 and set a “hold” rating for the company in a research note on Wednesday, August 5th. Needham & Company LLC boosted their price objective on Astera Labs from $260.00 to $425.00 and gave the company a “buy” rating in a report on Wednesday, August 5th. Finally, Rothschild & Co Redburn started coverage on Astera Labs in a report on Friday, May 1st. They set a “neutral” rating and a $153.00 price objective for the company. One analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and nine have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, Astera Labs currently has a consensus rating of “Moderate Buy” and a consensus price target of $325.25.

Insider Buying and Selling

In related news, Director Stefan A. Dyckerhoff sold 3,505 shares of the company’s stock in a transaction on Thursday, August 6th. The stock was sold at an average price of $311.83, for a total transaction of $1,092,964.15. Following the completion of the sale, the director owned 53,961 shares in the company, valued at approximately $16,826,658.63. This represents a 6.10% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Jack R. Lazar sold 10,000 shares of the company’s stock in a transaction on Thursday, June 4th. The stock was sold at an average price of $355.17, for a total value of $3,551,700.00. Following the sale, the director owned 75,688 shares of the company’s stock, valued at $26,882,106.96. This trade represents a 11.67% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 1,256,894 shares of company stock valued at $362,763,135. 10.40% of the stock is owned by company insiders.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.